PDS Biotechnology (PDSB) Tops Q3 EPS by 1c

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• AMD (AMD) PT Raised to $635 at Stifel as 'EPYC Server-CPU Franchise is an AI Winner'
• WD-40 (WDFC) PT Raised to $305 at DA Davidson